147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands

Neuromuscular Disorders

Volumn 18, Issue 1, 2008, Pages 90-96

  Sommer, C ^a   Brandner, S ^b   Dyck, P J ^c   Magy, L ^d   Mellgren, S I ^e   Morbin, M ^f   Schenone, A ^g   Tan, E ^h   Weis, J ⁱ  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MAYO CLINIC   (United States)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF TROMSØ   (Norway)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h HACETTEPE UNIVERSITY   (Turkey)

ⁱ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Diagnostic performance; Electron microscopy; Light microscopy; Nerve biopsy; Peripheral neuropathy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PARAFFIN;

ARTICLE; CEREBROSPINAL FLUID; ELECTRON MICROSCOPY; FROZEN SECTION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; NERVE BIOPSY; NETHERLANDS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SURAL NERVE; TREATMENT INDICATION;

AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; CYTOLOGICAL TECHNIQUES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NETHERLANDS; PATIENT SELECTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SURAL NERVE;

EID: 38649127200     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2007.08.010     Document Type: Article

References (31)

1. Gabriel C.M., Howard R., Kinsella N., Lucas S., McColl I., Saldanha G., et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 69 (2000) 442-446
2. Deprez M., de Groote C.C., Gollogly L., Reznik M., and Martin J.J. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord 10 (2000) 92-98
3. Dyck PJ, Dyck PJB, Engelstad JN. Pathological alterations of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005. p. 733-29.
4. Bosboom W.M., Van den Berg L.H., De Boer L., Van Son M.J., Veldman H., Franssen H., et al. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology 53 (1999) 837-845
5. Eurelings M., van den Berg L.H., Wokke J.H., Franssen H., Vrancken A.F., and Notermans N.C. Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy. Neurology 61 (2003) 707-709
6. Jann S., Bramerio M.A., Beretta S., Koch S., Defanti C.A., Toyka K.V., et al. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology 61 (2003) 1607-1610
7. Sommer C., Koch S., Lammens M., Gabreels-Festen A., Stoll G., and Toyka K.V. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 65 (2005) 1924-1929
8. Dyck P.J., Johnson W.J., Lambert E.H., and O'Brien P.C. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 46 (1971) 400-431
9. Haq R.U., Fries T.J., Pendlebury W.W., Kenny M.J., Badger G.J., and Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 57 (2000) 1745-1750
10. Bosboom W.M., van den Berg L.H., Franssen H., Giesbergen P.C., Flach H.Z., van Putten A.M., et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 124 (2001) 2427-2438
11. Dyck P.J., and Thomas P.K. Peripheral neuropathy. 4th ed. (2005), Elsevier, Philadelphia
12. King R. Atlas of peripheral nerve pathology (1999), Arnold, London
13. Schröder J.M. Pathologie peripherer Nerven (1999), Springer-Verlag, Berlin
14. Midroni G., and Bilbao J.M. Biopsy diagnosis of peripheral neuropathy (1995), Butterworth-Heinemann, Boston
15. Vital C., and Vallat J.M. Ultrastructural study of the human diseased peripheral nerve (1987), Elsevier, New York
16. Stendel C., Roos A., Deconinck T., Pereira J., Castagner F., Niemann A., et al. Peripheral nerve demyelination caused by a mutant rho GTPase guanine nucleotide exchange factor, Frabin/FGD4. Am J Hum Genet 81 (2007) 158-164
17. Yeung K.B., Thomas P.K., King R.H., Waddy H., Will R.G., Hughes R.A., et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238 (1991) 383-391
18. Ritz M.F., Erne B., Ferracin F., Vital A., Vital C., and Steck A.J. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve 22 (1999) 1030-1037
19. Gabriel J.M., Erne B., Bernasconi L., Tosi C., Probst A., Landmann L., et al. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol (Berl) 95 (1998) 540-546
20. Eurelings M., Moons K.G., Notermans N.C., Sasker L.D., De Jager A.E., Wintzen A.R., et al. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide. Neurology 56 (2001) 228-233
21. Satoi H., Oka N., Kawasaki T., Miyamoto K., Akiguchi I., and Kimura J. Mechanisms of tissue injury in vasculitic neuropathies. Neurology 50 (1998) 492-496
22. Kieseier B.C., Clements J.M., Pischel H.B., Wells G.M., Miller K., Gearing A.J., et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol 43 (1998) 427-434
23. Leppert D., Hughes P., Huber S., Erne B., Grygar C., Said G., et al. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53 (1999) 62-70
24. Kurz M., Pischel H., Hartung H.P., and Kieseier B.C. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. J Peripher Nerv Syst 10 (2005) 311-318
25. Sousa M.M., Du Yan S., Fernandes R., Guimaraes A., Stern D., and Saraiva M.J. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21 (2001) 7576-7586
26. Haslbeck K.M., Bierhaus A., Erwin S., Kirchner A., Nawroth P., Schlotzer U., et al. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 29 (2004) 853-860
27. Bierhaus A., Haslbeck K.M., Humpert P.M., Liliensiek B., Dehmer T., Morcos M., et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114 (2004) 1741-1751
28. Andorfer B., Kieseier B.C., Mathey E., Armati P., Pollard J., Oka N., et al. Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116 (2001) 226-232
29. Mazzeo A., Aguennouz M., Messina C., and Vita G. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch Neurol 61 (2004) 1097-1102
30. Vedeler C.A., Antoine J.C., Giometto B., Graus F., Grisold W., Hart I.K., et al. Management of paraneoplastic neurological syndromes: report of an EFNS task force. Eur J Neurol 13 (2006) 682-690
31. Vallat J.M., De M.H., Bordessoule D., Jauberteau M.O., Tabaraud F., Gelot A., and Vallat A.V. Non-Hodgkin malignant lymphomas and peripheral neuropathies - 13 cases. Brain 118 (1995) 1233-1245